MSCI’s flagship global equity index, is designed to represent performance of the full opportunity set of large- and mid-cap stocks across 23 developed and 26 emerging markets.

The MSCI ACWI Investable Market Index (IMI) is a widely quoted global equity index. Approximately USD 4.2 trillion in assets are benchmarked to the ACWI as of Dec. 31, 2020.*

ACWI Climate Pathway Select Index aims to represent the performance of a set of companies associated with the transition to a lower-carbon economy

MSCI ACWI ex Japan ex China A ESG Universal指数は、MSCIのESG Universal指数のメソドロジーをもとに銘柄選択と指数ウェイト調整を行う。

Just 15 years ago, corporate revenues from emerging markets (EM) represented around 10% of global revenues. 

The MSCI Emerging Markets(EM) Index was launched in 1988 including 10 countries with a weight of about 0.9% in the MSCI ACWI Index. Currently, it captures 26 countries across the globe and has a weight of 12% in the MSCI ACWI Index.

Three-quarters of the USD 1.5 trillion in revenue from clean tech for MSCI ACWI constituents came from outside North America. 

The weight of North American companies in global equity markets is at an all-time high, representing over 60% of market capitalization in the MSCI ACWI Index.

Although companies outside North America accounted for less than 40% of global equity market capitalization they captured almost 70% of the global revenues within the MSCI ACWI Index.

The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology.